Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Control Sample Collection and Labeling – V 2.0

Posted on By

API Manufacturing: SOP for Control Sample Collection and Labeling – V 2.0

Standard Operating Procedure for Control Sample Collection and Labeling in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/103/2025
Supersedes SOP/API/103/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for systematic collection, accurate labeling, and proper storage of control samples from each batch of API manufactured, to support future investigations, re-analysis, or stability studies as per regulatory requirements.

2. Scope

This SOP is applicable to production, quality control, and quality assurance personnel involved in sampling, labeling, and retention of control samples for both intermediates and final APIs.

3. Responsibilities

  • Production Chemist: Coordinate with QC for control sample collection after batch processing.
  • QC Analyst: Label, log, and store control samples as per defined procedures.
  • QA Officer: Ensure sample integrity, verify labeling accuracy, and approve storage location and duration.
See also  API Manufacturing: SOP for Use of Conductivity Meter in API Plant - V 2.0

4. Accountability

The QA Head is accountable for ensuring control sample management complies with cGMP requirements and regulatory expectations.

5. Procedure

5.1 Sample Quantity

  1. Collect at least twice the quantity required for a complete retesting of the material.
  2. For APIs: minimum 200 g or as per regulatory/customer-specific requirement.
  3. For intermediates (if retained): 50 g to 100 g depending on material nature.

5.2 Timing and Method of Collection

  1. Collect control samples after batch is declared conforming and QA-approved.
  2. Use clean, dry, inert, and appropriately sized containers (glass or HDPE with screw caps).
  3. Avoid exposure to air, light, or moisture during transfer.

5.3 Labeling Requirements

  1. Affix a control sample label (Annexure-1) with the following details:
    • Product Name
    • Batch Number
    • Manufacturing Date
    • Retest/Expiry Date
    • Storage Condition
    • Quantity Retained
    • Sample Code / Reference No.
    • Signature and Date
  2. Use indelible ink or pre-printed labels with QA verification.
See also  API Manufacturing: SOP for Rework and Reprocessing Guidelines - V 2.0

5.4 Storage Conditions

  1. Store samples in a designated Control Sample Room or Chamber.
  2. Conditions must be 25°C ± 2°C and 60% RH ± 5% unless specified otherwise.
  3. Samples must be segregated batch-wise, product-wise, and year-wise in clean labeled bins or racks.

5.5 Duration of Retention

  1. Retain samples for:
    • 1 year after batch expiry/retest date
    • Or as per contract/market regulations (e.g., 5 years for regulated markets)
  2. After expiry of the retention period, discard samples with QA authorization following the Sample Disposal SOP.

5.6 Documentation

  1. Record control sample collection in the Control Sample Logbook (Annexure-2).
  2. QA shall verify entry and sign off.
  3. Attach copy of label and sampling form to the Batch Manufacturing Record (BMR).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • API: Active Pharmaceutical Ingredient
  • BMR: Batch Manufacturing Record

See also  API Manufacturing: SOP for Monitoring of Reaction Parameters - V 2.0

7. Documents

  1. Control Sample Label Template (Annexure-1)
  2. Control Sample Logbook (Annexure-2)
  3. Sample Disposal Authorization Form

8. References

  • ICH Q7 – GMP for APIs
  • 21 CFR Part 211 – US FDA cGMP
  • WHO TRS 986 – GMP Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Control Sample Label

Product Name
Batch Number
Mfg. Date
Retest/Exp. Date
Quantity Retained
Sample Code
Storage Condition
Collected By
Date

Annexure-2: Control Sample Logbook

Date Batch No. Sample Code Quantity Storage Location QA Verified Remarks
13/04/2025 API-20250413 CS-104 200 g Rack B2 Stored

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Issue New SOP QA Head
13/04/2025 2.0 Label template added; retention period clarified Audit Improvement QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: BA-BE Studies: SOP for Label Generation and Sample Barcode Management – V 2.0
Next Post: Biosimilars: SOP for Audit Readiness of CLD Documentation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version